Literature DB >> 20009928

Biological modulation of renal ischemia-reperfusion injury.

Maarten G J Snoeijs1, L W Ernest van Heurn, Wim A Buurman.   

Abstract

PURPOSE OF REVIEW: Biological modulation of renal ischemia-reperfusion injury holds the potential to reduce the incidence of early graft dysfunction and to safely expand the donor pool with kidneys that have suffered prolonged ischemic injury before organ recovery. RECENT
FINDINGS: In the current review, we will discuss clinical studies that compare kidney transplant recipients with and without early graft dysfunction in order to elucidate the pathophysiology of ischemic acute allograft injury. We will specifically review the mechanisms leading to depression of the glomerular filtration rate and activation of the innate immune system in response to tissue injury.
SUMMARY: We conclude that the pathophysiology of delayed graft function after kidney transplantation is complex and shares broad similarity with rodent models of ischemic acute kidney injury. Given the lack of specific therapies to prevent delayed graft function in transplant recipients, comprehensive efforts should be initiated to translate the promising findings obtained in small animal models into clinical interventions that attenuate ischemic acute kidney injury after transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20009928     DOI: 10.1097/MOT.0b013e32833593eb

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  19 in total

1.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Evaluation of oxidant and antioxidant status in living donor renal allograft transplant recipients.

Authors:  Sunil Kumar; Ujjawal Sharma; Ashish Sharma; Deepesh B Kenwar; Sarbpreet Singh; Rajendra Prasad; Mukut Minz
Journal:  Mol Cell Biochem       Date:  2016-01-13       Impact factor: 3.396

3.  Folate receptor-targeted antioxidant therapy ameliorates renal ischemia-reperfusion injury.

Authors:  Sarah F Knight; Kousik Kundu; Giji Joseph; Sergey Dikalov; Daiana Weiss; Niren Murthy; W Robert Taylor
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 4.  Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

Authors:  Manjeri A Venkatachalam; Joel M Weinberg; Wilhelm Kriz; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2015-03-25       Impact factor: 10.121

5.  Serum neutrophil gelatinase-associated lipocalin and interleukin-18 as predictive biomarkers for delayed graft function after kidney transplantation.

Authors:  Eun Young Lee; Myoung Soo Kim; Yongjung Park; Hyon-Suk Kim
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

Review 6.  Acute kidney injury: a springboard for progression in chronic kidney disease.

Authors:  Manjeri A Venkatachalam; Karen A Griffin; Rongpei Lan; Hui Geng; Pothana Saikumar; Anil K Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-03

7.  Ischemic postconditioning at the initiation of cardiopulmonary resuscitation facilitates functional cardiac and cerebral recovery after prolonged untreated ventricular fibrillation.

Authors:  Nicolas Segal; Timothy Matsuura; Emily Caldwell; Mohammad Sarraf; Scott McKnite; Menekhem Zviman; Tom P Aufderheide; Henry R Halperin; Keith G Lurie; Demetris Yannopoulos
Journal:  Resuscitation       Date:  2012-04-18       Impact factor: 5.262

8.  Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury.

Authors:  Natasha M Rogers; Angus W Thomson; Jeffrey S Isenberg
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

9.  Role of reduced manganese superoxide dismutase in ischemia-reperfusion injury: a possible trigger for autophagy and mitochondrial biogenesis?

Authors:  Nirmala Parajuli; Lee Ann MacMillan-Crow
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-28

10.  Low molecular weight fucoidan against renal ischemia-reperfusion injury via inhibition of the MAPK signaling pathway.

Authors:  Jihui Chen; Weiling Wang; Quanbin Zhang; Fei Li; Tianluo Lei; Dali Luo; Hong Zhou; Baoxue Yang
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.